126 related articles for article (PubMed ID: 333701)
1. Extracorporeal treatment with membrane immobilized L-asparaginase in kidney transplantation.
Tapia LT; Hyden H; Wellner D; Cheigh JS; Stenzel KH; Rubin AL
Trans Am Soc Artif Intern Organs; 1977; 23():443-7. PubMed ID: 333701
[No Abstract] [Full Text] [Related]
2. Immunosuppressive activity of L-asparaginase.
Levin B; Merrill JP
Transplantation; 1971 Aug; 12(2):141-4. PubMed ID: 4936752
[No Abstract] [Full Text] [Related]
3. [Dynamics of changes in the subpopulations of rosette-forming B-lymphocytes during immunosuppressive therapy].
Voĭlokova RIa; Zaretskaia IuM; Rasulova TKh; Levitskiĭ ER
Probl Gematol Pereliv Krovi; 1980 May; 25(5):12-5. PubMed ID: 6995970
[No Abstract] [Full Text] [Related]
4. Prolongation of survival of allogeneic skin grafts by L-asparaginase. Preliminary report.
Hammer C; Brendel W
Eur Surg Res; 1971; 3(1):72-5. PubMed ID: 4939504
[No Abstract] [Full Text] [Related]
5. A new technique employing extracorporeal chemotherapy.
Sampson D; Hersh LS; Cooney D; Murphy GP
Trans Am Soc Artif Intern Organs; 1972; 18(0):54-9. PubMed ID: 4215192
[No Abstract] [Full Text] [Related]
6. Extracorporeal chemotherapy with L-asparaginase in man.
Sampson D; Han T; Hersh LS; Murphy GP
J Surg Oncol; 1974; 6(1):39-48. PubMed ID: 4206597
[No Abstract] [Full Text] [Related]
7. Prolongation of canine renal allograft survival by L asparaginase.
Rapaport FT; Shimada T; Watanabe K
Transplantation; 1971 Sep; 12(3):217-22. PubMed ID: 4936101
[No Abstract] [Full Text] [Related]
8. Prolongation of skin allograft survival in C57BL and C3H mice by L-asparaginase treatment.
Bertelli A; Donati L; Taidelli GA; Trabucchi E
Transplantation; 1971 Jan; 11(1):106-7. PubMed ID: 4927303
[No Abstract] [Full Text] [Related]
9. A new specific chemotherapy: a pilot study with an extracorporeal chamber.
Hydén H; Gelin LE; Larsson S; Saarne A
Rev Surg; 1974; 31(4):305-20. PubMed ID: 4610707
[No Abstract] [Full Text] [Related]
10. [Treatment of systemic lupus erythematosus with L-asparaginase: considerations on a case].
Pastor EM; Jamra M; Verrastro Almeida T; Saldanha RV; de Paula e Silva P; Kedor H; Serro A; de LG
Rev Hosp Clin Fac Med Sao Paulo; 1972; 27(3):129-33. PubMed ID: 5038988
[No Abstract] [Full Text] [Related]
11. [Proceedings: Leukocyte fall during extracorporal hemodialysis and its significance for immunosuppressive therapy in patients with recent kidney transplantation].
Löffler HD; Crössmann W; Heinze V
MMW Munch Med Wochenschr; 1975 May; 117(20):846. PubMed ID: 805991
[No Abstract] [Full Text] [Related]
12. Studies on neutralization of L-asparaginase activity in vitro and in vivo.
Vadlamudi S; Padarathsingh M; Bonmassar E; Waravdekar V; Goldin A
Cancer; 1971 Jun; 27(6):1321-7. PubMed ID: 4996690
[No Abstract] [Full Text] [Related]
13. Experimental investigations on problems of the clinical use of L-asparaginase.
Bierling R
Recent Results Cancer Res; 1970; 33():114-24. PubMed ID: 4115400
[No Abstract] [Full Text] [Related]
14. [Diagnostic value of T- and B- lymphocyte determination in patients with kidney allograft in the early post-transplantation period].
Voĭlokova RIa; Lobanova ED; Zaretskaia IuM; Rasulova TKh; Rasulova TKh
Sov Med; 1977 Nov; (11):29-33. PubMed ID: 343264
[No Abstract] [Full Text] [Related]
15. [On immunosuppression with levo-asparaginase in experimental renal allotransplantation. Preliminary note].
Rocchi V; Libra S; Gruttadauria G; Bordi A; Ricotta M
Chir Patol Sper; 1970 Aug; 18(4):207-14. PubMed ID: 4945263
[No Abstract] [Full Text] [Related]
16. Extracorporeal perfusion treatment with immobilized L-asparaginase.
Lange S; Hydén H
Scand J Haematol; 1977 Mar; 18(3):244-8. PubMed ID: 847397
[TBL] [Abstract][Full Text] [Related]
17. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].
Zhou J; Jin H; Li Y; Jiang T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852
[TBL] [Abstract][Full Text] [Related]
18. L-asparaginase reinduction and maintenance therapy in previously treated acute lymphocytic leukemia.
Sieger L; Higgins G; Ortega J; Shore N; Williams K
Med Pediatr Oncol; 1976; 2(3):327-32. PubMed ID: 1068340
[TBL] [Abstract][Full Text] [Related]
19. Use of immobilized L-asparaginase in acrylic microparticles in an extracorporeal hollow-fiber dialyzer.
Edman P; Nylén U; Sjöholm I
J Pharmacol Exp Ther; 1983 Apr; 225(1):164-7. PubMed ID: 6834269
[TBL] [Abstract][Full Text] [Related]
20. Enzyme therapy and immuno-adsorption by an extra-corporeal device.
Hydén H
Biomater Med Devices Artif Organs; 1980; 8(1):1-11. PubMed ID: 6988019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
